Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker

2015521 citationsJournal Articlebronze Open Access

Authors

Vivek Y. Reddy · Icahn School of Medicine at Mount Sinai

Derek V. Exner · Libin Cardiovascular Institute of Alberta

Daniel J. Cantillon · Cleveland Clinic

Rahul N. Doshi · Keck Hospital of USC

T. Jared Bunch · Intermountain Medical Center

Gery Tomassoni · Central Baptist Hospital

Paul A. Friedman

Abstract

The leadless cardiac pacemaker met prespecified pacing and sensing requirements in the large majority of patients. Device-related serious adverse events occurred in approximately 1 in 15 patients. (Funded by St. Jude Medical; LEADLESS II ClinicalTrials.gov number, NCT02030418.).

Topics & Keywords

Cardiac pacing and defibrillation studies Cardiac Arrhythmias and Treatments Cardiomyopathy and Myosin Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 373, Issue 12, pp. 1125-1135

DOI: 10.1056/nejmoa1507192

Field-Weighted Citation Impact: 44.41